Human Vaccines Market Analysis and Forecast 2017-2021

Human vaccines are dead or inactivated organisms or purified products derived from them. There are several types of vaccines currently in use. Conjugate vaccine is created by covalently attaching a poor antigen to a strong antigen thereby eliciting a stronger immunological response to the antigen, such as a polysaccharide that is attached to strong protein antigen. Inactivated vaccines are produced by killing the disease-causing microbe with chemicals, heat, or radiation. Live, attenuated vaccines contain a version of the living microbe that has been weakened in the lab so it can’t cause disease. Synthetic vaccine mainly consists of synthetic peptides, carbohydrates, or antigens, and they are usually considered to be safer than vaccines from bacterial cultures. New safe and effective vaccines are being developed for a variety of infections and parasites against which no effective preventive intervention measure is either available or practical.

Browse Human Vaccines Market by Vaccine Type (Conjugate Vaccines, Inactivated or Killed Vaccines, Live Attenuated Vaccines, Synthetic Vaccines, Others), Disease Type (Hepatitis, Human Papilloma Virus, Influenza, Pneumonia, Others) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/human-vaccines-market/

The global human vaccines market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global human vaccines market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global human vaccines market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global human vaccines market and profiled in this report include Bavarian Nordic, BioMérieux, Crucell, CSL Limited, Eli Lilly, Emergent BioSolutions, Inc., GlaxoSmithKline plc, Intercell, J&J/Janssen/Crucell, MedImmune, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Regeneron, Sanofi Pasteur, Sanofi-Aventis, Schering-Plough, Takeda Pharmaceutical Limited, and Teva Pharmaceuticals.

1. Vaccine Type
1.1. Conjugate Vaccines
1.2. Inactivated (Killed) Vaccines
1.3. Live, Attenuated Vaccines
1.4. Synthetic Vaccines
1.5. Others

2. Disease Type
2.1. Hepatitis
2.2. Human Papilloma Virus
2.3. Influenza
2.4. Pneumonia
2.5. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.3. Latin America (Brazil, Mexico, Rest of LA)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World (Middle East & Africa)

4. Company Profiles
4.1. Bavarian Nordic
4.2. BioMérieux
4.3. CSL Limited
4.4. Eli Lilly
4.5. Emergent BioSolutions, Inc.
4.6. GlaxoSmithKline plc
4.7. Intercell
4.8. J&J/Janssen/Crucell
4.9. MedImmune
4.10. Merck & Co., Inc.
4.11. Novartis AG
4.12. Pfizer, Inc.
4.13. Regeneron
4.14. Sanofi Pasteur
4.15. Schering-Plough
4.16. Takeda Pharmaceutical Limited
4.17. Teva Pharmaceuticals

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/human-vaccines-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.